ANTONIA ALCARAZ GARCÍA

Bernal E, Garcia-Villalba E, Pons E, Vicente MR, Tomas C, Minguela A; GERS. Role of vaccination and anti-SARS-CoV-2 antibodies in the clinical outcome of hospitalized COVID-19 patients. Med Clin (Barc). 2023 Jan 23:S0025-7753(23)00018-0. doi: 10.1016/j.medcli.2022.12.018. Online ahead of print. PubMed PMID: 36813683; PubMed Central PMCID: PMC9868359.

AÑO: 2023; IF: 3.9

36813683

Bernal E, Garcia-Villalba E, Pons E, Hernandez MD, Baguena C, Puche G, Carter P, Martinez M, Alcaraz A, Tomas C, Munoz A, Vicente MR, Nunez ML, Sancho N, Villalba MC, Cano A, Minguela A. Remdesivir plus dexamethasone is associated to improve the clinical outcome of COVID-19 hospitalized patients regardless of their vaccination status. Med Clin (Barc). 2023 Apr 5:S0025-7753(23)00173-2. doi: 10.1016/j.medcli.2023.03.025. Online ahead of print. English, Spanish. PubMed PMID: 37100681.

AÑO: 2023; IF: 3.9

37100681

Bernal E, Martinez M, Campillo JA, Puche G, Baguena C, Tomas C, Jimeno A, Alcaraz MJ, Alcaraz A, Munoz A, Oliver E, de la Torre A, Marin I, Cano A, Minguela A. Moderate to Intense Physical Activity Is Associated With Improved Clinical, CD4/CD8 Ratio, and Immune Activation Status in HIV-Infected Patients on ART. Open Forum Infect Dis. 2021 Dec 28;9(3):ofab654. doi: 10.1093/ofid/ofab654. eCollection 2022 Mar. Erratum In: Open Forum Infect Dis. 2022 Jul 13;9(7):ofac334. PubMed PMID: 35146043; PubMed Central PMCID: PMC8826224.

AÑO: 2022; IF: 4.2

35146043

Masiá M, Padilla S, Estañ G, Portu J, Silva A, Rivero A, González-Cordón A, García-Fraile L, Martínez O, Bernal E, Galera C, Boix Martínez V, Macias J, Montero M, García-Rosado D, Vivancos-Gallego MJ, Llenas-García J, Torralba M, García JA, Agulló V, González-Fernández M, Gutiérrez F, Martínez E; IMPAC-NEO Study Group. Impact of an enhanced screening program on the detection of non-AIDS neoplasias in patients with human immunodeficiency virus infection. Trials. 2021 Nov 27;22(1):851. doi: 10.1186/s13063-021-05777-6. PubMed PMID: 34838115; PubMed Central PMCID: PMC8626748.

AÑO: 2021; IF: 2.728

34838115

Bernal E, Gimeno L, Alcaraz MJ, Quadeer AA, Moreno M, Martínez-Sánchez MV, Campillo JA, Gomez JM, Pelaez A, García E, Herranz M, Hernández-Olivo M, Martínez-Alfaro E, Alcaraz A, Muñoz Á, Cano A, McKay MR, Muro M, Minguela A. Activating Killer-Cell Immunoglobulin-Like Receptors Are Associated With the Severity of Coronavirus Disease 2019. J Infect Dis. 2021 Jul 15;224(2):229-240. doi: 10.1093/infdis/jiab228. PubMed PMID: 33928374; PubMed Central PMCID: PMC8135764.

AÑO: 2021; IF: 7.759

33928374